Navigation Links
iSleep 20i self-adjusting CPAP

ProductsiSleep 20i self-adjusting CPAP
Company Breas Medical AB
Item iSleep 20i self-adjusting CPAP
Features 
  • Self-adjusting pressure through patented i-technology
  • Comprehensive yet easy to use PC-software with remote control capability
  • Detailed patient log displaying abnormal breathing
  • Memory card capability
  • Integrated AHI and leakage calculation
  • Enhanced User Interface yet extremely easy to use with big buttons
  • Large backlit graphical display with built-in alarm clock
  • Designed for travelling; world wide mains power compatibility and DC power options
  • Rear hose swivel connection
  • Designed for a wide range of masks
  • Power failure restart function
  • Extremely low noise
  • Unique snooze function
  • Small footprint even with the integrated humidifier attached
  • Designed for home
Description iSleep 20i is an advanced high performance CPAP with outstanding self-adjusting i‑technology.
Info Breas Medical AB
Customer Service: +46 31 86 88 00
Web site: http://www.breas.se/

Related medicine products :

1. Spine-Tract Anterior Lumbar Retractor System
2. Thompson Surgical Radiotranslucent Anterior Lumbar Retractor System
3. Jaguar Lumbar I/F Cage System
4. IBS® Allograft Lumbar
5. Horizontal-Vertical (H/V) Lumbar Valve Systems
6. Spine-Tract Posterior Lumbar Retractor System
7. Corlok Lumbar Allograft System
8. Duet Lumbar Allograft System
9. Solo Lumbar Allograft System
10. FastSystem® AF400 Anterior Lumbar Retractor System
11. Karlin Lumbar Microdiscectomy Curette
Subretinal Fluid Cannula, Straight; 20g (0.90) x 1-1/2" (38mm); 12mm Flexible Tubing Extends 6mm Beyond Tip....
Micro Vitreoretinal Cannula; Angled; 20g (0.90) x 1" (25mm); Tip Extension: 3mm, 32g (0.23); Angled at 65°, 1mm from Tip....
...
...
Medicine Products:
(Date:12/14/2009)... Sedwitz Heads up 900-Member Physician Staff , ... La ... Jolla have elected Marc Sedwitz, MD, as the new chief of ... head of the 900-member physician team on Jan. 1, 2010. , ... as medical staff liaison to Scripps La Jolla’s administrative staff and ...
(Date:12/14/2009)... ,, NEW YORK, Dec. 14 /PRNewswire-USNewswire/ -- ... -- the largest survey on teen drug abuse tracking ... that teens, intentional abuse of prescription (Rx) and over-the-counter ... with an alarming number of young people abusing medicines ... Teen Abuse of Medication Continues to Be a ...
(Date:12/14/2009)... Federation of America (HFA) expresses its concern regarding ... 929 and the American Red Cross of Pennsylvania ... skilled workers to provide clean, safe blood to ... as clotting factor for use in treating hemophilia ... of Blood Services at the American Red Cross ...
(Date:12/14/2009)... Exercise benefited men whose disease had been treated, hadn,t ... -- Exercise appears to reduce the risk of death ... study, which began in January 1986, included 668 men ... stage III colon cancer that had not spread (nonmetastatic ... that asked them about any new cancer and disease ...
(Date:12/14/2009)... finds, , , MONDAY, Dec. 14 (HealthDay News) -- Here,s ... without a cup or two of java: Coffee and ... 2 diabetes. , That,s the conclusion of an ... drink, the lower your risk of diabetes. Every cup ... in the risk of diabetes, the researchers said. ...
Breaking Medicine News(10 mins):Health News:New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla 2Health News:New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla 3Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 2Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 3Health News:HFA Voices Blood Safety Concerns 2Health News:Physical Activity May Prolong Survival After Colon Cancer 2Health News:Coffee, Tea Might Stave Off Diabetes 2Health News:Coffee, Tea Might Stave Off Diabetes 3
... heart surgery in Malaysia. This has increased the pressure on ... anywhere between two to six months. To tide over the ... rise to the occasion and provide affordable heart surgery to ... the provisions in the Private Healthcare Facilities and Services (PHFS) ...
... For a while, road accidents were the biggest killers. Now ... Clostridium difficile, is equivalent// to the fatalities caused by road ... geriatric medicine at the University of Edinburgh, has provided statistics ... by 5.5 per cent annually; in contrast, MRSA cases had ...
... Foundation on Wednesday announced that it will spend $500 ... address childhood obesity//, particularly targeting minority children, who are ... ,Nearly 25 million children under age 18 are considered ... medical expenses, according to the foundation. ,The ...
... signed an exclusive worldwide Collaborative Research and License ... technologies, including the Medidur technology in ophthalmic applications. ... pSivida will receive up to $155 million in ... ,Pfizer will have an exclusive license to market ...
... antibody (mAb) product has entered a phase I clinical ... study in the US. , ,Crucell has ... prophylaxis of rabies, using Crucell’s MAbstract and Crucell’s PER.C6 ... to the initial phase I study that is currently ...
... seems to be receiving in its efforts to patent its ... and Trademark Office has made a preliminary decision to revoke ... the last few years. ,Patent examiners rejected all the ... James A.Thomson of the University of Wisconsin, perhaps the first ...
Other Medicine News:Health News:Crucell's Rabies MAb Enters Phase I Trial in India 2
(Date:12/14/2009)... Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT ) today ... Allowance from the United States Patent and Trademark ... no. 11/060,641, which covers the composition and use ... the lead Transcept product candidate. Once issued, ... 2025. ,, "This is the second USPTO Notice ...
(Date:12/14/2009)... -- In response to an FDA notice ... the Agency recommended that healthcare facilities discontinue use ... system, hospitals throughout the U.S. are faced with ... product. According to the FDA, STERIS made changes ... affect the safety or the effectiveness of the ...
(Date:12/14/2009)... Dec. 14 The board of directors of ... today declared a dividend for the first quarter of ... ,, The dividend is payable March 10, ... business on ,, February 12, 2010. ,, Lilly, ... of pharmaceutical products by applying the latest research from ...
Breaking Medicine Technology:Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R) 2Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R) 3Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R) 4ECRI Institute Issues Steris System 1 High Priority Alert and Recommendations: Free Guidance to Help Hospitals Map out Transition to Alternative Reprocessing Methods 2ECRI Institute Issues Steris System 1 High Priority Alert and Recommendations: Free Guidance to Help Hospitals Map out Transition to Alternative Reprocessing Methods 3Pharma and Biotech Leaders to Converge in Shanghai 14765 1Pharma and Biotech Leaders to Converge in Shanghai 14765 2CEL SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 14763 1CEL SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 14763 2CEL SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 14763 3AMD LASERS Names Dr James Jesse as Medical Director 6091 1AMD LASERS Names Dr James Jesse as Medical Director 6091 2